Te Yi Pharmaceutical: It is expected that the net profit will increase by 241.55% to 339.13% in 2025 compared to the previous year.

Special Pharmaceutical announced that it is expected to achieve a net profit of 70-90 million yuan in 2025, an increase of 241.55% - 339.13% year-on-year. The company's performance change is the result of deepening marketing transformation, advancing brand strategy, and the recovery of products. With the joint promotion of core product sales rebounding, optimized marketing channels, and other factors, the company's operating income and comprehensive gross profit margin have shown a good recovery. Despite the short-term impact of brand building investment on profits, the overall operating profit of the company has still achieved positive improvement, reflecting that marketing transformation and brand building have achieved good results.